Guidance document - Nonprescription topical nasal decongestants labelling standard

This labelling standard describes the requirements necessary to receive market authorisation ( Drug identification number (DIN)) for nonprescription topical nasal decongestant products containing oxymetazoline hydrochloride or xylometazoline hydrochloride as a single ingredient for use in adults and children 12 years of age and older to relieve nasal congestion.

Data and Resources

Additional Info

Field Value
Last Updated April 17, 2026, 17:45 (UTC)
Created April 17, 2026, 17:45 (UTC)
criticality_level []
geographic_scope []
open_canada_collection publication
open_canada_date_published 2017-05-18 00:00:00
open_canada_keywords {"fr": ["Décongestionnants nasaux topiques en vente libre", "norme d'étiquetage", "autorisation de mise sur le marché", "chlorhydrate d'oxymétazoline", "chlorhydrate de xylométazoline"], "en": ["Non-prescription topical nasal decongestants", "labelling standard", "market authorisation", "oxymetazoline hydrochloride", "xylometazoline hydrochloride"]}
open_canada_subject ["health_and_safety"]
sensitivity_level unrestricted
title_fr Ligne directrice - Norme d'étiquetage des médicaments décongestionnants nasaux topiques vendus sans ordonnance
update_frequency as_needed